LEADER |
00740nam a2200205Ia 4500 |
001 |
1555433 |
040 |
|
|
|a غير محدد
|
041 |
|
|
|a eng
|
100 |
|
|
|a Rehab Helmy Mohammed Ibrahim
|e معد
|
245 |
|
|
|a The impact of CYP2C9*3 and calumenin genetic polymorphisms on warfarin dose requirements
|
246 |
|
|
|a Study on possible protective effects of certain natural products against experimentally induced hepatotoxicity in rats
|
260 |
|
|
|c 2015
|
336 |
|
|
|a رسائل جامعية
|
502 |
|
|
|c Faculty of Pharmacy / Department of Pharmacology and Toxicology / Cairo University
|
502 |
|
|
|g مصر
|
653 |
|
|
|a Pharmacology and Toxicology
|
653 |
|
|
|a Pharmacy
|
940 |
|
|
|a تمت المناقشة
|
995 |
|
|
|a Thesis
|
999 |
|
|
|c 276398
|d 276398
|